Accessibility Menu
 
PDS Biotechnology logo

PDS Biotechnology

(NASDAQ) PDSB

Current Price$1.43
Market Cap$79.82M
Since IPO (2019)-84%
5 Year-70%
1 Year+9%
1 Month+35%

PDS Biotechnology Financials at a Glance

Market Cap

$79.82M

Revenue (TTM)

$0.00

Net Income (TTM)

$34.50M

EPS (TTM)

$-0.67

P/E Ratio

-2.13

Dividend

$0.00

Beta (Volatility)

2.01 (High)

Price

$1.43

Volume

39,356

Open

$1.33

Previous Close

$1.43

Daily Range

$1.29 - $1.54

52-Week Range

$0.51 - $1.92

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PDS Biotechnology

Industry

Biotechnology

Employees

21

CEO

Frank K. Bedu-Addo, PhD

Headquarters

Princeton, NJ 07932, US

PDSB Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-254%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-46.95%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$79.82M

Shares Outstanding

55.82M

Volume

39.36K

Avg. Volume

798.48K

Financials (TTM)

Gross Profit

$60.52K

Operating Income

$31.54M

EBITDA

$30.30M

Operating Cash Flow

$27.75B

Capital Expenditure

$0.00

Free Cash Flow

$27.75B

Cash & ST Invst.

$26.71M

Total Debt

$5.19B

PDS Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$15.13K

-0.0%

Gross Margin

0.00%

N/A

Market Cap

$79.82M

N/A

Market Cap/Employee

$3.33M

N/A

Employees

24

N/A

Net Income

$7.56M

+4.9%

EBITDA

$6.44M

+5.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$5.17B

-26107.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$11.76M

+26.9%

Short Term Debt

$5.17B

+41031.2%

Return on Assets

-1.13%

N/A

Return on Invested Capital

-1.50%

N/A

Free Cash Flow

$3.70M

+55.0%

Operating Cash Flow

$3.70M

+55.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KZRKezar Life Sciences, Inc.
$7.29+0.00%
XLOXilio Therapeutics, Inc.
$8.81+13.53%
LVTXLAVA Therapeutics N.V.
$1.74-3.87%
OKUROnKure Therapeutics, Inc.
$3.34-1.76%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$11.21+0.27%
FFord Motor Company
$14.48+0.07%
AIIORobo.ai
$5.64+1.16%
NOKNokia
$14.46-0.02%

Questions About PDSB

What is the current price of PDS Biotechnology?

PDS Biotechnology is trading at $1.43 per share.

What is the 52-week range for PDS Biotechnology?

Over the past 52 weeks, PDS Biotechnology has traded between $0.51 and $1.92.

How much debt does PDS Biotechnology have?

As of the most recent reporting period, PDS Biotechnology reported total debt of $10.61M.

How much cash does PDS Biotechnology have on hand?

PDS Biotechnology reported $21.66M in cash and cash equivalents in its most recent financial results.

What is PDS Biotechnology’s dividend yield?

PDS Biotechnology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.